Valuation: MindMaze Therapeutics Holding SA

Market Cap 30.4M 37.57M 32.66M 27.91M 52.7M 3.59B 53.52M 358M 141M 1.79B 141M 138M 5.99B P/E 2026 *
-4.43x
P/E 2027 * 1.56x
Enterprise Value 21.98M 27.16M 23.61M 20.18M 38.11M 2.59B 38.7M 259M 102M 1.29B 102M 99.78M 4.33B EV / Sales 2026 *
3.73x
EV / Sales 2027 * 0.26x
Free-Float
38.51%
Yield 2026 *
-
Yield 2027 * -
1 day+0.61%
1 week+26.08%
1 month-9.04%
3 months-37.94%
6 months-81.45%
Current year-89.52%
1 week 0.16
Extreme 0.16
0.22
1 month 0.15
Extreme 0.1518
0.22
Current year 0.15
Extreme 0.1518
1.87
1 year 0.15
Extreme 0.1518
2.92
3 years 0.15
Extreme 0.1518
2.92
5 years 0.15
Extreme 0.1518
2.92
10 years 0.15
Extreme 0.1518
2.92
Date Insider Type Main position Quantity % Market Cap.
12/19/25 A Sell 140,000 0.0908%
12/19/25 A Sell 52,162 0.0338%
12/19/25 A Sell 281,968 0.1830%
Change 5-day change 1-year change 3-year change Capi.($)
+0.61%+26.08% - - 37.57M
-1.40%+2.59%-1.71%+11.28% 48.53B
-2.41%-0.90%+411.96%+495.33% 39.87B
-1.16%+12.96%+28.81%+7.25% 38.68B
-1.88%-3.03%+5.69%+53.00% 35.13B
-1.74%+5.12%+14.44%+41.77% 29.79B
-0.21%-4.04%+36.40%+125.75% 16.11B
-2.85%-3.92% - - 16.08B
-0.64%+2.65%+3.40%+13.11% 13.61B
-1.19%-1.32%-1.73%-34.37% 12.62B
Average -1.29%+3.56%+62.16%+89.14% 25.05B
Weighted average by Cap. -1.60%+2.04%+79.78%+108.61%

Financials

2026 *2027 *
Net sales 5.9M 7.29M 6.34M 5.42M 10.23M 696M 10.39M 69.55M 27.29M 347M 27.39M 26.78M 1.16B 43.19M 53.37M 46.4M 39.65M 74.88M 5.1B 76.04M 509M 200M 2.54B 200M 196M 8.51B
Net income -7.81M -9.65M -8.39M -7.17M -13.54M -922M -13.75M -92.07M -36.14M -459M -36.25M -35.46M -1.54B 24.83M 30.68M 26.67M 22.79M 43.05M 2.93B 43.71M 293M 115M 1.46B 115M 113M 4.89B
Net Debt -8.42M -10.41M -9.05M -7.73M -14.6M -993M -14.82M -99.24M -38.95M -494M -39.08M -38.22M -1.66B -19.27M -23.81M -20.7M -17.69M -33.41M -2.27B -33.93M -227M -89.14M -1.13B -89.44M -87.47M -3.8B
Logo MindMaze Therapeutics Holding SA
MindMaze Therapeutics Holding SA, formerly known as RELIEF THERAPEUTICS Holding SA, is a Switzerland-based company that engages in research, development, production, and sale of biotechnology, pharmaceutical, diagnostic, therapeutic, chemical, and cosmetic products. The Company acquires and manages patents, licenses, and intellectual property, provides preclinical, clinical, and regulatory services, and may establish subsidiaries worldwide. The Company also participates in the acquisition, holding, and financing of interests in companies, offers management services to affiliates, and develops scientific and economic solutions for disease treatment and therapeutic approaches. Additionally, the Company may acquire, hold, and sell trademarks and other IP rights globally, and provide or obtain financing through loans or guarantees to support its corporate purpose.
Employees
10
Date Price Change Volume
31/07/26 CHF 0.1992 +0.61% 1,358,761
30/07/26 CHF 0.1980 +2.17% 1,081,702
29/07/26 CHF 0.1938 +14.00% 1,150,889
28/07/26 CHF 0.1700 -5.56% 1,528,357
27/07/26 CHF 0.1800 +13.92% 2,599,726
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Annual profits - Rate of surprise